Lyra Therapeutics Inc (LYRA)

Mar 31, 2025

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates - Nasdaq

Mar 31, 2025

Mar 28, 2025

Lyra Therapeutics stock hits 52-week low at $0.14 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Lyra Therapeutics stock hits 52-week low at $0.14 amid sharp decline - Investing.com Australia

Mar 28, 2025

Mar 19, 2025

Lyra Therapeutics stock plunges to 52-week low of $0.16 By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 18, 2025

Lyra Therapeutics stock plunges to 52-week low of $0.16 - Investing.com India

Mar 18, 2025

Mar 17, 2025

Analysts Set Lyra Therapeutics, Inc. (NASDAQ:LYRA) Target Price at $4.50 - Defense World

Mar 17, 2025

Mar 17, 2025

Analysts Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $9.33 - Defense World

Mar 17, 2025

Mar 16, 2025

Lyra Therapeutics (NASDAQ:LYRA) Earns “Neutral” Rating from HC Wainwright - Defense World

Mar 16, 2025

Mar 15, 2025

Lyra Therapeutics Reports 2024 Financial Results and Updates - TipRanks

Mar 15, 2025

Mar 13, 2025

Arbor Realty Trust Closes a $1.15 Billion Repurchase Facility to Unwind Two Outstanding Collateralized Loan Obligations - The Manila Times

Mar 13, 2025

Mar 13, 2025

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 13, 2025

Mar 13, 2025

FDA Green Light: Lyra's Nasal Polyp Treatment Advances as 52-Week Data Shows Promise - StockTitan

Mar 13, 2025

Mar 13, 2025

Lyra Therapeutics reports Q4 EPS ($1.43), consensus (13c) - TipRanks

Mar 13, 2025

Mar 13, 2025

Lyra Therapeutics (LYRA) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025

Mar 11, 2025

Zevra Therapeutics (ZVRA) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 11, 2025

Mar 07, 2025

Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace

Mar 07, 2025

Mar 06, 2025

Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions - Bain Capital

Mar 06, 2025

Mar 05, 2025

Lyra Therapeutics Inc (LYRA) expanding its growth trajectory ahead - SETE News

Mar 05, 2025

Mar 03, 2025

Chronic Rhinosinusitis Pipeline 2024: FDA Updates, Therapy - openPR.com

Mar 03, 2025

Feb 26, 2025

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates - Nasdaq

Feb 26, 2025

Feb 26, 2025

Dream Finders Homes (NASDAQ:DFH) Shares Gap Up Following Better-Than-Expected Earnings - Defense World

Feb 26, 2025

Feb 25, 2025

Comparing Lyra Therapeutics (NASDAQ:LYRA) & Anika Therapeutics (NASDAQ:ANIK) - Defense World

Feb 25, 2025

Feb 25, 2025

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Down on Disappointing Earnings - Defense World

Feb 25, 2025

Feb 25, 2025

Head to Head Analysis: Kymera Therapeutics (NASDAQ:KYMR) and Creative Medical Technology (NASDAQ:CELZ) - Defense World

Feb 25, 2025

Feb 11, 2025

Watch this stock’s price performance: Lyra Therapeutics Inc (NASDAQ:LYRA) - US Post News

Feb 11, 2025

Feb 10, 2025

Lyra Therapeutics Inc (LYRA) receives a Hold rating from Jefferies - Knox Daily

Feb 10, 2025

Feb 10, 2025

Examining the Potential Price Growth of Oshkosh Corp (OSK) - Knox Daily

Feb 10, 2025

Feb 10, 2025

Neuronetics Inc [STIM] Stock sold by Insider Furlong Stephen for $1122.0 - Knox Daily

Feb 10, 2025

Feb 10, 2025

BrightSpire Capital Inc [BRSP] Insider Activity: An Update for Investors - Knox Daily

Feb 10, 2025

Feb 07, 2025

LYRA’s 2023 Market Dance: Down -5.96% – Time to Invest? - The InvestChronicle

Feb 07, 2025

Feb 07, 2025

Lyra Therapeutics Inc (LYRA) Shares Rise Despite Market Challenges - The News Heater

Feb 07, 2025

Feb 07, 2025

TD Cowen Initiates Coverage on Palvella Therapeutics (NASDAQ:PVLA) - Defense World

Feb 07, 2025

Feb 05, 2025

Deeper Dive: Understanding Immunome Inc (IMNM) Through its Various Ratios - The Dwinnex

Feb 05, 2025

Jan 23, 2025

LYRA News Today | Why did Lyra Therapeutics stock go up today? - MarketBeat

Jan 23, 2025

Jan 18, 2025

Selling Your Galaxy Payroll Group Ltd (GLXG) Stock? Here’s What You Need To Know - Stocks Register

Jan 18, 2025

Jan 18, 2025

New Outlook On ReNew Energy Global plc - Stocks Register

Jan 18, 2025

Jan 18, 2025

Open Lending Corp’s (LPRO) Stock Is Harder To Predict Than You Think - Stocks Register

Jan 18, 2025

Jan 18, 2025

There Is A Lot Of Upside Potential For Helius Medical Technologies Inc(NASDAQ: HSDT) - Stocks Register

Jan 18, 2025

Jan 18, 2025

New Outlook On Vestis Corp - Stocks Register

Jan 18, 2025

Jan 18, 2025

Data-Based Insights About MINISO Group Holding Ltd ADR (MNSO) - Stocks Register

Jan 18, 2025

Jan 11, 2025

Lyra Therapeutics (LYRA) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jan 11, 2025

Jan 09, 2025

Chronic Rhinosinusitis Without Nasal Polyps Therapeutics - openPR

Jan 09, 2025

Jan 08, 2025

Revance Therapeutics jumps after Teoxane offers $3.60 a share - MSN

Jan 08, 2025

Jan 08, 2025

Cidara Therapeutics Announces Leadership Changes and Appointments - MSN

Jan 08, 2025

Jan 06, 2025

Are Investors Keen On Selling Holdings In Phoenix Motor Inc (NASDAQ: PEV)? - Stocks Register

Jan 06, 2025

Jan 05, 2025

State Street Corp Takes Position in Lotus Technology Inc. (NASDAQ:LOT) - Defense World

Jan 05, 2025